ⓘ Transaldolase deficiency

                                     

ⓘ Transaldolase deficiency

Transaldolase deficiency is a disease characterised by abnormally low levels of the Transaldolase enzyme. It is a metabolic enzyme involved in the pentose phosphate pathway. It is caused by mutation in the transaldolase gene. It was first described by Verhoeven et al. in 2001.

                                     
  • ATP, DNA, and RNA. Transaldolase links the pentose phosphate pathway to glycolysis. In patients with deficiency of transaldolase there s an accumulation
  • Transaldolase 1 is a protein that in humans is encoded by the TALDO1 gene. Transaldolase 1 is a key enzyme of the nonoxidative pentose phosphate pathway
  • 1016 S0031 - 9422 00 91430 - 4. Horecker, B. L Smyrniotis, P. Z 1953 Transaldolase The Formation of Fructose - 6 - Phosphate from Sedoheptulose - 7 - Phosphate
  • EC 2.2. This category consists of various transketolases and transaldolases Transaldolase the namesake of aldehyde transferases, is an important part
  • glyceraldehyde 3 - phosphate G3P during glycolysis. Transketolase and transaldolase convert two molecules of F6P and one molecule of G3P to three molecules
  • 2004 ZNF143 mediates basal and tissue - specific expression of human transaldolase J. Biol. Chem. 279 13 12190 205. doi: 10.1074 jbc.M307039200. PMID 14702349
  • SALL1 Townes Brocks syndrome 107480 SALL1 Transaldolase deficiency 606003 TALDO1 Transcobalamin II deficiency 275350 TCN2 Transient bullous of the newborn